Sepsis-associated acute kidney damage is a disease that affects the patient's quality of life. It should be a target for gene therapy
Sepsis-associated acute kidney damage is a disease that affects the patient's quality of life as well as their chances of dying. While supportive care can be useful for helping patients live longer if their health improves, there are no therapies that are directed at modifying the underlying pathophysiology. More recent studies show that changes in gene expression, protein abundance, and metabolism can alter kidney function in sepsis, which further demonstrates how far we've come in the past decade when it comes to our understanding of the underlying mechanisms of sickness. While significant progress has been made, the opportunity provided by current omic technologies to illuminate these paths has yet to be realized.To help us provide better healthcare for our sickest patients, we're recommending future research go along the following lines: First, conduct in-depth research on recent advancements in both fundamental and clinical science to take advantage of new imaging technologies that have been developed in the last several years. Next, exploit recent breakthroughs in fundamental and clinical science to use new imaging technologies that have been established over the last several years.